HDL THERAPY: ADDRESSING RESIDUAL RISK IN TREATING CAD

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

MASKON OTEH

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Seminar Paper

Paper Information

Seminar: INTERNATIONAL CONGRESS OF METABOLIC SYNDROME, OBESITY & DIABETES
Year:2010 | Issue:2

Download Full-Text

View:

128

Download:

Information Seminar Paper

Title

HDL THERAPY: ADDRESSING RESIDUAL RISK IN TREATING CAD

Author(s)

MASKON OTEH

Keywords

Not Registered.

Abstract

UNDERSTANDING THE STRUCTURE AND METABOLISM OF HDL IS ESSENTIAL FOR COMPREHENSIVE MANAGEMENT OF DYSLIPIDAEMIA. EPIDEMIOLOGICAL STUDIES HAVE ESTABLISHED THE RELATIONSHIP OF LOW-HDL WITH INCREASED INCIDENCE OF CORONARY ARTERY DISEASE. HOWEVER, THUS FAR, LESS CERTAINTY IS OBSERVED ON THE EFFECT OF HDL REDUCING THERAPY IN THE SUBSEQUENT REDUCTION OF CAD. HDL RAISING CAN BE OBTAINED VIA DIETARY, EXERCISE AND OTHER NON-PHARMACOLOGICAL MEANS. PHARMACOLOGICAL TREATMENT AVAILABLE CURRENTLY ARE NICOTINIC ACID, FIB RATE AND STATINS (EITHER AS MONOTHERAPY OR COMBINATION). THERE ARE OTHER AGENTS THAT HAVE BEEN SHOWN TO INCREASE HDL, UNFORTUNATELY WITH PARADOXICAL OUTCOMES. IN SHORT, CURRENT TREATMENT OF LOW HDL IS STILL FAR FROM SATISFACTORY. HOWEVER, TREATING THE OVERALL PROFILE OF DYSLIPIDAEMIA (INCLUDING TARGETING THE LDL AND TG) HAS BEEN PROVEN TO BE MORE PRODUCTIVE.

Cites

No record.

References

No record.

Cite

APA: Copy

MASKON, OTEH. (2010). HDL THERAPY: ADDRESSING RESIDUAL RISK IN TREATING CAD. INTERNATIONAL CONGRESS OF METABOLIC SYNDROME, OBESITY & DIABETES. SID. https://sid.ir/paper/905193/en

Vancouver: Copy

MASKON OTEH. HDL THERAPY: ADDRESSING RESIDUAL RISK IN TREATING CAD. 2010. Available from: https://sid.ir/paper/905193/en

IEEE: Copy

OTEH MASKON, “HDL THERAPY: ADDRESSING RESIDUAL RISK IN TREATING CAD,” presented at the INTERNATIONAL CONGRESS OF METABOLIC SYNDROME, OBESITY & DIABETES. 2010, [Online]. Available: https://sid.ir/paper/905193/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops